SCHEMBL4217062

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL25415133	0.86	ALDH1A1 (0.33)	LMNATSHR
	SCHEMBL28709803	0.78	—	—
	SCHEMBL10836314	0.76	OPRM1 (0.48)	DNM1CA1LMNATSHR
	SCHEMBL28938913	0.74	SMN1; SMN2 (0.35)	LMNATSHRMEN1KMT2A
	SCHEMBL7872144	0.72	—	—
	SCHEMBL28938914	0.72	LMNA (0.38)	LMNATSHRTRPV1MEN1KMT2A
	SCHEMBL26245	0.71	LMNA (0.53)	NFKB1DNM1CA12CA1CA2
	SCHEMBL31333173	0.71	NFKB1 (0.47)	NFKB1DNM1CA12CA1CA2
	SCHEMBL9836643	0.71	—	—
	SCHEMBL104004	0.71	—	—

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.